0.3 |
1.4 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
0.3 |
1.0 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.3 |
2.1 |
GO:0034616 |
response to laminar fluid shear stress(GO:0034616) |
0.3 |
3.2 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 |
2.2 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
0.3 |
0.8 |
GO:0043371 |
negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.3 |
0.8 |
GO:0001757 |
somite specification(GO:0001757) |
0.2 |
0.7 |
GO:0010586 |
miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.2 |
1.8 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 |
0.7 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
0.2 |
0.6 |
GO:0002740 |
negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.2 |
0.6 |
GO:0021896 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
0.2 |
0.7 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
0.2 |
0.9 |
GO:0045953 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.2 |
0.7 |
GO:0006848 |
pyruvate transport(GO:0006848) |
0.2 |
0.5 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 |
1.5 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
0.1 |
0.3 |
GO:0045750 |
obsolete positive regulation of S phase of mitotic cell cycle(GO:0045750) |
0.1 |
0.4 |
GO:0070672 |
response to interleukin-12(GO:0070671) response to interleukin-15(GO:0070672) |
0.1 |
0.6 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
0.1 |
0.8 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
0.1 |
0.4 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 |
1.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
0.1 |
0.9 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
0.1 |
0.3 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 |
0.3 |
GO:0051097 |
negative regulation of helicase activity(GO:0051097) |
0.1 |
0.3 |
GO:0003289 |
septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.1 |
0.7 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
0.1 |
0.2 |
GO:2000794 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.1 |
0.5 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 |
0.4 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
0.1 |
0.5 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
0.1 |
0.9 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 |
0.2 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 |
1.0 |
GO:0046839 |
phospholipid dephosphorylation(GO:0046839) |
0.1 |
0.4 |
GO:0046778 |
modification by virus of host mRNA processing(GO:0046778) |
0.1 |
0.4 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 |
0.7 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
0.1 |
0.3 |
GO:0035470 |
positive regulation of vascular wound healing(GO:0035470) |
0.1 |
0.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
0.1 |
0.7 |
GO:0046146 |
tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 |
0.5 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 |
0.4 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 |
0.2 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
0.1 |
0.2 |
GO:0006562 |
proline catabolic process(GO:0006562) |
0.1 |
0.2 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
0.1 |
1.0 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
0.1 |
0.2 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 |
0.3 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
0.1 |
0.1 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
0.1 |
0.7 |
GO:0048557 |
embryonic digestive tract morphogenesis(GO:0048557) |
0.1 |
0.6 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
0.1 |
0.4 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
0.1 |
0.3 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 |
0.3 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
0.1 |
0.2 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
0.1 |
0.7 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 |
0.4 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
0.1 |
0.3 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
0.1 |
0.7 |
GO:0016180 |
snRNA processing(GO:0016180) |
0.1 |
0.2 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 |
0.2 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
0.1 |
0.3 |
GO:0032736 |
positive regulation of interleukin-13 production(GO:0032736) |
0.1 |
0.3 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 |
0.2 |
GO:2000189 |
regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 |
0.2 |
GO:0048263 |
determination of dorsal identity(GO:0048263) |
0.1 |
0.2 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 |
0.4 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 |
0.7 |
GO:0032876 |
regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.1 |
0.7 |
GO:0046718 |
viral entry into host cell(GO:0046718) |
0.1 |
0.2 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.1 |
0.2 |
GO:0051958 |
methotrexate transport(GO:0051958) |
0.1 |
0.2 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
0.1 |
1.6 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
0.1 |
0.4 |
GO:0031657 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 |
0.2 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) actin filament reorganization(GO:0090527) |
0.1 |
0.2 |
GO:0007518 |
myoblast fate determination(GO:0007518) |
0.1 |
0.3 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
0.1 |
1.1 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
0.1 |
0.5 |
GO:0043545 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 |
0.3 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
0.0 |
0.4 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
0.0 |
0.2 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
0.0 |
0.2 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
0.0 |
0.1 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.0 |
0.4 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
0.0 |
0.1 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
0.0 |
1.6 |
GO:0030866 |
cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.0 |
0.3 |
GO:0007500 |
mesodermal cell fate determination(GO:0007500) |
0.0 |
0.2 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.0 |
0.1 |
GO:0043418 |
cysteine biosynthetic process from serine(GO:0006535) homoserine metabolic process(GO:0009092) cysteine biosynthetic process via cystathionine(GO:0019343) transsulfuration(GO:0019346) homocysteine catabolic process(GO:0043418) |
0.0 |
0.3 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
0.0 |
0.3 |
GO:0043113 |
receptor clustering(GO:0043113) |
0.0 |
0.1 |
GO:0010107 |
potassium ion import(GO:0010107) |
0.0 |
0.3 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
0.0 |
0.2 |
GO:0003078 |
obsolete regulation of natriuresis(GO:0003078) |
0.0 |
0.2 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 |
0.2 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
0.0 |
0.3 |
GO:0015705 |
iodide transport(GO:0015705) |
0.0 |
0.6 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
0.0 |
0.1 |
GO:0072369 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.0 |
0.3 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 |
0.5 |
GO:0001885 |
endothelial cell development(GO:0001885) |
0.0 |
0.1 |
GO:0007285 |
primary spermatocyte growth(GO:0007285) |
0.0 |
0.2 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
0.0 |
1.0 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
0.0 |
0.1 |
GO:0000187 |
activation of MAPK activity(GO:0000187) positive regulation of MAP kinase activity(GO:0043406) |
0.0 |
0.3 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
0.0 |
0.1 |
GO:0000114 |
obsolete regulation of transcription involved in G1 phase of mitotic cell cycle(GO:0000114) |
0.0 |
0.6 |
GO:0007281 |
germ cell development(GO:0007281) |
0.0 |
0.7 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
0.0 |
0.1 |
GO:0002385 |
innate immune response in mucosa(GO:0002227) mucosal immune response(GO:0002385) response to lipid hydroperoxide(GO:0006982) |
0.0 |
1.3 |
GO:0007224 |
smoothened signaling pathway(GO:0007224) |
0.0 |
1.0 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
0.0 |
0.2 |
GO:0030514 |
regulation of BMP signaling pathway(GO:0030510) negative regulation of BMP signaling pathway(GO:0030514) |
0.0 |
0.3 |
GO:0033261 |
obsolete regulation of S phase(GO:0033261) |
0.0 |
0.1 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
0.0 |
1.0 |
GO:0016925 |
protein sumoylation(GO:0016925) |
0.0 |
0.1 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.0 |
0.4 |
GO:0001893 |
maternal placenta development(GO:0001893) |
0.0 |
0.2 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
0.0 |
0.1 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 |
0.2 |
GO:0034331 |
cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.0 |
0.2 |
GO:0045329 |
amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 |
0.7 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
0.0 |
0.1 |
GO:0008228 |
opsonization(GO:0008228) |
0.0 |
1.3 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
0.0 |
0.6 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
0.0 |
2.3 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
0.0 |
0.4 |
GO:0001709 |
cell fate determination(GO:0001709) |
0.0 |
0.1 |
GO:0051383 |
kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.0 |
0.1 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
0.0 |
0.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 |
0.1 |
GO:1902692 |
regulation of neuroblast proliferation(GO:1902692) |
0.0 |
0.2 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
0.0 |
0.5 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
0.0 |
0.2 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 |
0.1 |
GO:0048799 |
endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) ossification involved in bone maturation(GO:0043931) organ maturation(GO:0048799) bone maturation(GO:0070977) bone growth(GO:0098868) |
0.0 |
0.1 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 |
2.0 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 |
0.1 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 |
0.2 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 |
0.9 |
GO:0060041 |
retina development in camera-type eye(GO:0060041) |
0.0 |
0.6 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 |
0.1 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
0.0 |
0.1 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
0.0 |
0.4 |
GO:1902583 |
multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.0 |
0.3 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 |
0.4 |
GO:0065004 |
protein-DNA complex assembly(GO:0065004) |
0.0 |
0.1 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 |
0.2 |
GO:0009308 |
amine metabolic process(GO:0009308) |
0.0 |
0.1 |
GO:0040015 |
stress granule assembly(GO:0034063) negative regulation of multicellular organism growth(GO:0040015) |
0.0 |
0.1 |
GO:0060123 |
regulation of growth hormone secretion(GO:0060123) positive regulation of growth hormone secretion(GO:0060124) |
0.0 |
0.9 |
GO:0060828 |
regulation of canonical Wnt signaling pathway(GO:0060828) |
0.0 |
0.1 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 |
0.2 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
0.0 |
0.5 |
GO:0042472 |
inner ear morphogenesis(GO:0042472) |
0.0 |
0.2 |
GO:0014037 |
Schwann cell differentiation(GO:0014037) |
0.0 |
0.1 |
GO:0035019 |
somatic stem cell population maintenance(GO:0035019) |
0.0 |
0.2 |
GO:0045446 |
endothelium development(GO:0003158) endothelial cell differentiation(GO:0045446) |
0.0 |
0.2 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
0.0 |
0.4 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 |
0.2 |
GO:0050687 |
negative regulation of defense response to virus(GO:0050687) |
0.0 |
0.1 |
GO:0007091 |
metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) regulation of mitotic sister chromatid segregation(GO:0033047) metaphase/anaphase transition of cell cycle(GO:0044784) chromosome separation(GO:0051304) mitotic sister chromatid separation(GO:0051306) |
0.0 |
0.1 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 |
0.0 |
GO:0035283 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 |
0.2 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
0.0 |
0.6 |
GO:0030183 |
B cell differentiation(GO:0030183) |
0.0 |
0.4 |
GO:0050663 |
cytokine secretion(GO:0050663) |
0.0 |
4.6 |
GO:0000122 |
negative regulation of transcription from RNA polymerase II promoter(GO:0000122) |
0.0 |
0.1 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
0.0 |
0.8 |
GO:1903037 |
regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
0.0 |
0.1 |
GO:0007140 |
male meiosis(GO:0007140) |
0.0 |
0.1 |
GO:0098762 |
meiotic prophase I(GO:0007128) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 |
0.0 |
GO:0051593 |
response to folic acid(GO:0051593) |
0.0 |
0.2 |
GO:0031055 |
DNA replication-independent nucleosome assembly(GO:0006336) chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) centromere complex assembly(GO:0034508) DNA replication-independent nucleosome organization(GO:0034724) CENP-A containing chromatin organization(GO:0061641) |
0.0 |
0.1 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
0.0 |
0.1 |
GO:0043010 |
camera-type eye development(GO:0043010) |
0.0 |
0.3 |
GO:0009187 |
cyclic nucleotide metabolic process(GO:0009187) |
0.0 |
0.1 |
GO:2000124 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 |
0.1 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 |
0.1 |
GO:0018101 |
protein citrullination(GO:0018101) |